Medigus Ltd (Israel) Valuation Overview

MDGS -- Israel Stock  

ILS 56.90  0.70  1.22%

Medigus Ltd secures last-minute Real Value of S59.35 per share. The latest price of the firm is S56.9. At this time the firm appears to be under valued. Macroaxis forecasts value of Medigus Ltd from analyzing the firm fundamentals such as Price to Earning of 77.14times, Current Valuation of 11.86M and Return On Equity of (39.67)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Horizon     30 Days    Login   to change
Medigus Ltd is considered to be number one stock in beta category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about  38.17  of Price to Sales per Beta.

Current Market Valuation

Medigus Ltd Valuation Boundaries

Under Valued
October 22, 2018
Market Value
Real Value
Target Odds
Medigus Ltd is not very risky asset. Calculation of real value of Medigus Ltd is based on 1 month time horizon. Increasing Medigus Ltd time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Please see also Stocks Correlation. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.